Peptide record

TPDB11553

Antibacterial Anticancer Antifungal Antiparasitic Antiviral standard
34 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB11553
Antibacterial Anticancer Antifungal Antiparasitic Antiviral
Anti-infective peptides Cancer-related peptides
AntiBP3 dbAMP DRAMP pep-lab Peptipedia Antifungipept CAFPdb AI4AVP dbAMP 3.0 DRAVP 2.0
standard
No
A 34-aa standard-residue multi-activity (Antibacterial, Anticancer, Antifungal, and other sources) peptide sequence curated from AntiBP3, dbAMP, DRAMP, and other sources, with an available 3D structural model.
Sequence
GICACRRRFCPNSERFSGYCRVNGARYVRCCSRR
Physicochemical Analysis

Sequence-only estimates for a linear peptide with free termini, not experimentally measured molecular properties. Mass and formula exclude cyclization and disulfide formation. The optical estimates assume paired cysteines, 280 nm, 1 g/L and a 1 cm path. The N-end rule estimate is not a measured plasma half-life.

C163H265N63O44S6
DQHLKMTW
R
4003.65
10.26
9
1
9
+8
3.88
-0.638
34.41
Mammalian: 30 hour Yeast: >20 hour E.coli: >10 hour
3355
0.84
13
Residue Composition
number
2
A
9
R
2
N
0
D
6
C
1
E
0
Q
3
G
0
H
1
I
0
L
0
K
0
M
2
F
1
P
3
S
0
T
0
W
2
Y
2
V
Amino Acid Distribution
A: 2 R: 9 N: 2 D: 0 C: 6 E: 1 Q: 0 G: 3 H: 0 I: 1 L: 0 K: 0 M: 0 F: 2 P: 1 S: 3 T: 0 W: 0 Y: 2 V: 2
Chemical Descriptors
34 reviewed residue count
C163H265N63O44S6 sequence-only estimate (linear, free termini)
4003.65 sequence-only estimate (linear, free termini)
10.26 sequence-only estimate (linear, free termini)
+8 sequence-only estimate (linear, free termini)
3.88 sequence-only estimate (linear, free termini)
-0.638 sequence-only estimate (linear, free termini)
Evidence Records 4 records
Evidence 1 Activity

Activity

Antibacterial

Source & Reference

dbAMP DRAMP

Other

Source Activity Label Source Definition
Antibacterial
dbAMP classified as Antibacterial under the Anti-bacterial function class.
log deduction after 20 min incubation with 50 ug/ml peptide. Active against S. aureus strains 566, 502A, J.F. (reduction 0-1.3 logs), S. epidermidis UCLA-622 (reduction 1.3 logs), S. pneumoniae Type III (reduction >3.5 log), S. agalactiae Type I-A or III (reduction 0.3-0.6 logs), L. monocytogenes 450 (reduction 0.2 logs), P. aeruginosa PAO579 (reduction 3.3 logs), E. coli ATCC 29648 (reduction 0.6 logs), K. pneumoniae ATCC 13883 (reduction 2.4 logs), S. marcescens (reduction 0.5 log), H. influenzae Type 3A (reduction >1.1 log), B. bronchiseptica UCLA-342 (reduction 0.1 log).
Evidence 2 Activity

Activity

Antifungal

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

Source Activity Label Source Definition
Antifungal
dbAMP classified under the Anti-fungal function class.
log deduction after 20 min incubation with 50 ug/ml peptide. Active against S. aureus strains 566, 502A, J.F. (reduction 0-1.3 logs), S. epidermidis UCLA-622 (reduction 1.3 logs), S. pneumoniae Type III (reduction >3.5 log), S. agalactiae Type I-A or III (reduction 0.3-0.6 logs), L. monocytogenes 450 (reduction 0.2 logs), P. aeruginosa PAO579 (reduction 3.3 logs), E. coli ATCC 29648 (reduction 0.6 logs), K. pneumoniae ATCC 13883 (reduction 2.4 logs), S. marcescens (reduction 0.5 log), H. influenzae Type 3A (reduction >1.1 log), B. bronchiseptica UCLA-342 (reduction 0.1 log).
Evidence 3 Activity

Activity

Antiparasitic

Source & Reference

dbAMP 3.0 DRAMP

Other

Source Activity Label Source Definition
Antiparasitic
dbAMP 3.0 classified under the Anti-parasitic function class.
log deduction after 20 min incubation with 50 ug/ml peptide. Active against S. aureus strains 566, 502A, J.F. (reduction 0-1.3 logs), S. epidermidis UCLA-622 (reduction 1.3 logs), S. pneumoniae Type III (reduction >3.5 log), S. agalactiae Type I-A or III (reduction 0.3-0.6 logs), L. monocytogenes 450 (reduction 0.2 logs), P. aeruginosa PAO579 (reduction 3.3 logs), E. coli ATCC 29648 (reduction 0.6 logs), K. pneumoniae ATCC 13883 (reduction 2.4 logs), S. marcescens (reduction 0.5 log), H. influenzae Type 3A (reduction >1.1 log), B. bronchiseptica UCLA-342 (reduction 0.1 log).
Evidence 4 Activity

Activity

Antiviral

Source & Reference

dbAMP 3.0 DRAMP DRAVP 2.0

Other

Source Activity Label Source Definition
Antiviral
dbAMP 3.0 classified under the Anti-viral function class.
log deduction after 20 min incubation with 50 ug/ml peptide. Active against S. aureus strains 566, 502A, J.F. (reduction 0-1.3 logs), S. epidermidis UCLA-622 (reduction 1.3 logs), S. pneumoniae Type III (reduction >3.5 log), S. agalactiae Type I-A or III (reduction 0.3-0.6 logs), L. monocytogenes 450 (reduction 0.2 logs), P. aeruginosa PAO579 (reduction 3.3 logs), E. coli ATCC 29648 (reduction 0.6 logs), K. pneumoniae ATCC 13883 (reduction 2.4 logs), S. marcescens (reduction 0.5 log), H. influenzae Type 3A (reduction >1.1 log), B. bronchiseptica UCLA-342 (reduction 0.1 log).